Effect of vincristine on the bone marrow cells of patients with multiple myeloma: A cytomorphologic study

A. Riccardi, C. Montecucco, R. Cresci, E. Traversi, S. Perugini

Research output: Contribution to journalArticlepeer-review


The cytologic changes induced by vincristine (VCR) on the erythroblasts, the myeloid cells and the neoplastic plasma cells were studied on the bone marrow of 5 patients with plasma cell malignancies. Nine hours after the administration of the drug, the cytocidal effect on the 3 cell types was proportional to the magnitude of the sathmokinetic effect induced in them: marked on the erythroblasts (whose percentage incidence was sharply reduced), more modest on the myeloid cells, and still lower on the plasma cells. Nine days later the plasmocytomatous infiltrate was reduced as compared to before therapy, while the aliquot of hemopoietic cells was restored. At this time the mitotic index of plasma cells, but not that of the hemopoietic cells, was higher than before VCR administration. These findings suggest that the tumor mass reduction by VCR is followed by plasma cell recruitment, which is in progress 9 days after the drug administration. On the contrary, the regeneration of the hemopoietic cells has repopulated the bone marrow and is already exhausted in this lag time. It is hypothesized that VCR administrations given at about 9 day intervals are more and more effective on the recruited plasma cells, owing to the phase S-specificity of the drug. The regeneration of the hemopoietic cells is protected by this time interval.

Original languageEnglish
Pages (from-to)319-329
Number of pages11
Issue number3
Publication statusPublished - 1980

ASJC Scopus subject areas

  • Cancer Research


Dive into the research topics of 'Effect of vincristine on the bone marrow cells of patients with multiple myeloma: A cytomorphologic study'. Together they form a unique fingerprint.

Cite this